The Foundation for Sarcoidosis Research (FSR) has invested $1 million in its new Clinical and Research Fellowship Program. It also…
Articles by Iqra Mumal, PhD
Radiotherapy may be useful for the control of sarcoidosis associated with bone involvement, according to a recent case report. “…
Treatment with Remicade (infliximab) in neurosarcoidosis patients is associated with favorable imaging and clinical treatment responses, new research shows. The…
Tumor necrosis factor (TNF) antagonists are effective therapies in a significant proportion of patients with severe and refractory sarcoidosis, a…
A new study reports that 16.5% of sarcoidosis patients experience EDS (excessive daytime sleepiness), 16.4% experience severe fatigue, and 6.3%…